88IV - PR Newswire Asia's news


DualityBio (9606.HK) Announces 2025 Annual Results HONG KONG , March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" or the "Company"), a leading ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab) Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF Revenue amounted to approximately RMB2057.92 million, and gross profit amounted to approximately RMB1478.78 million, representing a year-on-year increase. R&D Expenses was approximately RMB1319.68 ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery CAMBRIDGE, Mass. , March 23, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the ... 2026-03-23T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Cambrex Advances US and European Expansions EAST RUTHERFORD, N.J. , March 23, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the completion of initial engineering studies ... 2026-03-23T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies MELBOURNE, Australia , March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced ... 2026-03-23T Biotechnology Education Health Care/Hospital Higher Education
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , March 23, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ... 2026-03-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study SAN FRANCISCO and SUZHOU, China , March 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ... 2026-03-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target SHANGHAI , March 22, 2026 /PRNewswire/ -- On the occasion of World Water Day, WuXi Biologics reaffirms its commitment to sustainability through responsible operations and efficient, circular water‑use ... 2026-03-22T Biotechnology Environmental Products & Services Health Care/Hospital

PR Newswire Asia's news > Biotechnology